Skip to main content

Table 1 Patient and treatment characteristics

From: Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer

Characteristics Value (%)
Median age, years (range) 57 (30-84)
Gender  
   Male 40 (59.7)
   Female 27 (40.3)
Stage at initial diagnosis  
   ypStage 0 3 (4.2)
   pStage I/ypStage I 5 (7.0)/1 (1.4)
   pStage II/ypStage II 14 (19.7)/3 (4.2)
   pStage III/ypStage III 21 (29.6)/8 (11.3)
   pStage IV/ypStage IV 6 (8.5)/1 (1.4)
   pT1-2Nx 5 (7.0)
Recurrence history  
   0 51 (76.1)
   1 16 (23.9)
Symptoms at recurrence  
   Yes 20 (29.9)
   No 47 (70.1)
Recurrent site  
   Central 21 (31.3)
   Lateral 30 (44.8)
   Posterior 16 (23.9)
Pretreatment CEA  
   Normal (≤ 5 ng/mL) 37 (55.2)
   High (> 5 ng/mL) 30 (44.8)
Salvage treatment  
   Surgery + CRT 45 (67.2)
   CRT alone 22 (32.8)
Chemotherapy regimen  
   Fluoropyrimidine-alone 35 (52.2)
   Irinotecan or Oxaliplatin-based 31 (46.3)
   No 1 (1.5)
Radicality of resection  
   R0 19 (28.4)
   R1 24 (35.8)
   R2 2 (4.0)
   No surgery 22 (32.8)
Median radiation dose, Gy (range) 57.2 (44.3-74.4)
  1. Values in parentheses are percentages unless indicated otherwise. CRT, chemoradiotherapy; R0, microscopically radical; R1, microscopically irradical; R2, macroscopically irradical; Gy, Gray; CEA, carcinoembryonic antigen.